|
|
|
|
| LEADER |
01782cam a22004217a 4500 |
| 001 |
MUB01000868585 |
| 003 |
CZ BrMU |
| 005 |
20230611174325.0 |
| 008 |
130805s2009 xxu||||| |||||||||||eng d |
| STA |
|
|
|a POSLANO DO SKCR
|b 2023-07-14
|
| 020 |
|
|
|a 978-0-471-75477-0
|q (set)
|
| 020 |
|
|
|a 978-0-471-75399-5
|
| 040 |
|
|
|a BOD034
|b cze
|d BOD114
|
| 072 |
|
7 |
|a 577
|x Biochemie. Molekulární biologie. Biofyzika
|2 Konspekt
|9 2
|
| 080 |
|
|
|a 577.1
|2 MRF
|
| 245 |
0 |
0 |
|a Wiley encyclopedia of chemical biology.
|n Volume 1,
|p ADME properties of drugs to Essential fatty acids : physiology and clinical significance /
|c Tadhg P. Begley, chief advisor
|
| 246 |
3 |
0 |
|a Encyclopedia of chemical biology
|
| 260 |
|
|
|a Hoboken, N.J. :
|b John Wiley & Sons,
|c c2009
|
| 300 |
|
|
|a xx, 721 s :
|b il.
|
| 504 |
|
|
|a Obsahuje bibliografii a rejstřík
|
| 650 |
0 |
7 |
|a biochemie
|7 ph114149
|2 czenas
|
| 650 |
0 |
9 |
|a biochemistry
|2 eczenas
|
| 700 |
1 |
|
|a Begley, Tadhg P.
|7 uk2009539247
|4 edt
|
| CAT |
|
|
|a VARTECKAX
|b 02
|c 20130805
|l MUB01
|h 1307
|
| CAT |
|
|
|a VASICEK
|b 02
|c 20131218
|l MUB01
|h 0928
|
| CAT |
|
|
|a VASICEK
|b 02
|c 20131218
|l MUB01
|h 0930
|
| CAT |
|
|
|a VASICEK
|b 02
|c 20140102
|l MUB01
|h 1425
|
| CAT |
|
|
|c 20140127
|l MUB01
|h 1924
|
| CAT |
|
|
|c 20150404
|l MUB01
|h 0800
|
| CAT |
|
|
|a BATCH
|b 00
|c 20151226
|l MUB01
|h 0413
|
| CAT |
|
|
|c 20210614
|l MUB01
|h 1005
|
| CAT |
|
|
|c 20210614
|l MUB01
|h 1953
|
| CAT |
|
|
|a HANAV
|b 02
|c 20230611
|l MUB01
|h 1743
|
| CAT |
|
|
|c 20230714
|l MUB01
|h 1122
|
| LOW |
|
|
|a POSLANO DO SKCR
|b 2023-07-14
|
| 994 |
- |
1 |
|l MUB01
|l MUB01
|m BOOK
|1 KUK
|a Knihovna univ. kampusu
|2 VV
|b KUK - volný výběr
|3 549(03)-WILE
|5 3284008076
|7 Stay in the library
|8 20130805
|f 70
|f Prezenční
|g 2013-1359
|r 20131231
|s kup
|
| AVA |
|
|
|a MED50
|b KUK
|c KUK - volný výběr
|d 549(03)-WILE
|e available
|t K dispozici
|f 1
|g 0
|h N
|i 0
|j VV
|k 0
|
